Cancer drug company OncoMed upsizes IPO at $17 as biotech offerings boom
July 18, 2013 at 02:12 AM EDT
OncoMed Pharmaceuticals Inc. either underestimated or over-delivered on its IPO, but the result is an $81...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.